Grifols, S.A. (GRF) - Financial and Strategic SWOT Analysis Review

Date: February 9, 2016
Pages: 64
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G7A3D62774BEN
Leaflet:

Download PDF Leaflet

Grifols, S.A. (GRF) - Financial and Strategic SWOT Analysis Review
Grifols, S.A. (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief Summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Grifols, S.A. (Grifols) is a pharmaceutical and chemical company focused at improving the health and well being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, diagnostic products and hospital pharmacy products. It produces plasma derived protein therapies for patients suffering with rare, genetic diseases and life-threatening infections. Grifols provides healthcare professionals, hospitals and pharmacies with tools they need to deliver expert medical care. The company has plasma donation centers across the US and industrial facilities in Australia, Mexico, Switzerland, the US and Spain.

Grifols, S.A. Key Recent Developments

Dec 14,2015 Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company
Nov 30,2015 Inauguration of the Grifols Chair for the Study of Cirrhosis
Oct 28,2015 Grifols agrees long term loan with the European Investment Bank
Oct 22,2015 Grifols official opening of the Bioscience Division new worldwide operations facility in Ireland

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Grifols, S.A. - Key Facts
Grifols, S.A. - Key Employees
Grifols, S.A. - Key Employee Biographies
Grifols, S.A. - Major Products and Services
Grifols, S.A. - Pharmaceutical Pipeline Products Data
Grifols, S.A., Pipeline Products by Therapy Area
Grifols, S.A., Pipeline Products by Development Phase
Grifols, S.A. - Medical Equipment Pipeline Products Data
Grifols, S.A. Pipeline Products by Equipment Type
Grifols, S.A. Pipeline Products by Development Stage
Grifols, S.A. - History
Grifols, S.A. - Company Statement
Grifols, S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Grifols, S.A. - Business Description
Grifols, S.A. - Corporate Strategy
Grifols, S.A. - SWOT Analysis
SWOT Analysis - Overview
Grifols, S.A. - Strengths
Strength - Focused Research and Development
Strength - Plasma Products
Strength - Robust Manufacturing Base
Grifols, S.A. - Weaknesses
Weakness - Product Recall
Weakness - Trial Termination
Grifols, S.A. - Opportunities
Opportunity - Strategic Acquisitions
Opportunity - Business Initiatives
Opportunity - Strategic Agreements
Grifols, S.A. - Threats
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Threat - Rapid Technological Changes
Threat - Changing Diagnostic Market Conditions
Grifols, S.A. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Grifols, S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Type, 2010 to YTD 2016
Grifols, S.A., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Dec 14, 2015: Grifols makes public its succession plan: the envisaged generational handover reiterates the commitment of the founding family to the company
Nov 30, 2015: Inauguration of the Grifols Chair for the Study of Cirrhosis
Oct 28, 2015: Grifols agrees long term loan with the European Investment Bank
Oct 22, 2015: Grifols official opening of the Bioscience Division new worldwide operations facility in Ireland
Jun 30, 2015: ISD completes single envelope ‘clad rack’ cold storage facility for Spanish pharmaceutical giant Grifols
Feb 26, 2015: Grifols achieves a record net profit of 470.3 million euros with growth of 36.1% in 2014
Feb 16, 2015: Grifols PhocusRx Certified DIACAP Compliant
Feb 05, 2015: SIPPET Study on inhibitors in Hemophilia A: interim analysis confirms the original hypothesis
Jan 21, 2015: Grifols Academy of Plasmapheresis Awarded ACCET Accreditation
Jan 02, 2015: Grifols new immunoglobulin purification plant in the United States receives FDA approval

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Grifols, S.A., Key Facts
Grifols, S.A., Key Employees
Grifols, S.A., Key Employee Biographies
Grifols, S.A., Major Products and Services
Grifols, S.A., Number of Pipeline Products by Therapy Area
Grifols, S.A., Number of Pipeline Products by Development Stage
Grifols, S.A., Pipeline Products By Therapy Area and Development Phase
Grifols, S.A. Number of Pipeline Products by Equipment Type
Grifols, S.A. Pipeline Products by Equipment Type
Grifols, S.A. Number of Pipeline Products by Development Stage
Grifols, S.A. Pipeline Products by Development Stage
Grifols, S.A., History
Grifols, S.A., Other Locations
Grifols, S.A., Subsidiaries
Grifols, S.A., Key Competitors
Grifols, S.A., Ratios based on current share price
Grifols, S.A., Annual Ratios
Grifols, S.A., Interim Ratios
Grifols, S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Type, 2010 to YTD 2016
Grifols, S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Grifols, S.A., Pipeline Products by Therapy Area
Grifols, S.A., Pipeline Products by Development Phase
Grifols, S.A. Pipeline Products by Equipment Type
Grifols, S.A. Pipeline Products by Development Stage
Grifols, S.A., Performance Chart (2010 - 2014)
Grifols, S.A., Ratio Charts
Grifols, S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Grifols, S.A., Medical Equipment, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Grifols, S.A. (GRF) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: